Johnson & Johnson vaccine will cost less than $ 10 and be released in 2021

Pharmaceutical company Janssen, owned by U.S. multinational Johnson & Johnson, plans to have the vaccine against covid-19, which Spain is participating in phase III trials for, in the second half of 2021 at a price of less than $ 10.

This was revealed on Thursday by Johnson & Johnson Executive Committee Vice Chairman Joaquín Duato during a conference at the Health Sector Sectoral Meeting, organized by IESE Business School, with the collaboration of the consultancy firm. McKinsey & Company.

The study, approved yesterday in Spain by the Spanish Medicines and Health Products Agency, plans to guarantee the vaccine “at some point in the first or second half of 2021,” he said.

The early clinical results from Pfizer and Moderna, with an efficacy of 95%, are numbers that represent “good omen” for the rest of the pharmaceutical companies focused on the same protein.

As the head of Johnson & Johnson reports, the pharmaceutical company has been working in the supply chain to be able to offer a billion vaccines in 2021 through a collaborative network.

“Over the next six months there will be good news, we can see how these effective vaccines will be available to the public,” said Duato, who took the opportunity to point out that the vaccine his team is working on will also guarantee “ quality and safety standards. »Announced by other companies in the sector.

The speaker applauded the collaboration between partners in the pharmaceutical industry to find a vaccine: “This is not a competitive situation, it is a societal problem and a global crisis in which we will need several vaccines, not one, because we have to immunize millions of people. “.

To ensure that the population is immunized, Johnson & Johnson is working with governments on access and distribution plans, like COVAX, a project they will allocate 500 million doses of their production to for low-income countries.

From the multinational, they assure that the price will not be focused on profit: “We will seek to guarantee access to the vaccine in all territories, the price will not exceed 10 USD per vaccine.”



Protective measures

Map of infected people